232 related articles for article (PubMed ID: 24132695)
1. Ab initio study on the noncovalent adsorption of camptothecin anticancer drug onto graphene, defect modified graphene and graphene oxide.
Saikia N; Deka RC
J Comput Aided Mol Des; 2013 Sep; 27(9):807-21. PubMed ID: 24132695
[TBL] [Abstract][Full Text] [Related]
2. Molecular modeling studies of the DNA-topoisomerase I ternary cleavable complex with camptothecin.
Fan Y; Weinstein JN; Kohn KW; Shi LM; Pommier Y
J Med Chem; 1998 Jun; 41(13):2216-26. PubMed ID: 9632354
[TBL] [Abstract][Full Text] [Related]
3. Investigation of graphene-based nanomaterial as nanocarrier for adsorption of paclitaxel anticancer drug: a molecular dynamics simulation study.
Hasanzade Z; Raissi H
J Mol Model; 2017 Feb; 23(2):36. PubMed ID: 28120117
[TBL] [Abstract][Full Text] [Related]
4. Theoretical Study on the Aggregation and Adsorption Behaviors of Anticancer Drug Molecules on Graphene/Graphene Oxide Surface.
Gong P; Zhou Y; Li H; Zhang J; Wu Y; Zheng P; Jiang Y
Molecules; 2022 Oct; 27(19):. PubMed ID: 36235277
[TBL] [Abstract][Full Text] [Related]
5. Role of the protein in the DNA sequence specificity of the cleavage site stabilized by the camptothecin topoisomerase IB inhibitor: a metadynamics study.
Coletta A; Desideri A
Nucleic Acids Res; 2013 Dec; 41(22):9977-86. PubMed ID: 24003027
[TBL] [Abstract][Full Text] [Related]
6. An ab initio quantum mechanics calculation that correlates with ligand orientation and DNA cleavage site selectivity in camptothecin-DNA-topoisomerase I ternary cleavage complexes.
Xiao X; Cushman M
J Am Chem Soc; 2005 Jul; 127(28):9960-1. PubMed ID: 16011334
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of two models for human topoisomerase I interaction with dsDNA and camptothecin derivatives.
Laco GS
PLoS One; 2011; 6(8):e24314. PubMed ID: 21912628
[TBL] [Abstract][Full Text] [Related]
8. Sequence selectivity of the cleavage sites induced by topoisomerase I inhibitors: a molecular dynamics study.
Siu FM; Pommier Y
Nucleic Acids Res; 2013 Dec; 41(22):10010-9. PubMed ID: 24021629
[TBL] [Abstract][Full Text] [Related]
9. Action models for the antitumor drug camptothecin: formation of alkali-labile complex with DNA and inhibition of human DNA topoisomerase I.
Streltsov SA
J Biomol Struct Dyn; 2002 Dec; 20(3):447-54. PubMed ID: 12437383
[TBL] [Abstract][Full Text] [Related]
10. Effect of E-ring modifications in camptothecin on topoisomerase I inhibition: a quantum mechanics treatment.
Xiao X; Cushman M
J Org Chem; 2005 Nov; 70(23):9584-7. PubMed ID: 16268636
[TBL] [Abstract][Full Text] [Related]
11. Dynamic Cooperation of Hydrogen Binding and π Stacking in ssDNA Adsorption on Graphene Oxide.
Xu Z; Lei X; Tu Y; Tan ZJ; Song B; Fang H
Chemistry; 2017 Sep; 23(53):13100-13104. PubMed ID: 28714285
[TBL] [Abstract][Full Text] [Related]
12. Human topoisomerase I inhibition: docking camptothecin and derivatives into a structure-based active site model.
Laco GS; Collins JR; Luke BT; Kroth H; Sayer JM; Jerina DM; Pommier Y
Biochemistry; 2002 Feb; 41(5):1428-35. PubMed ID: 11814334
[TBL] [Abstract][Full Text] [Related]
13. Screening of the structural, topological, and electronic properties of the functionalized Graphene nanosheets as potential Tegafur anticancer drug carriers using DFT method.
Shahabi M; Raissi H
J Biomol Struct Dyn; 2018 Aug; 36(10):2517-2529. PubMed ID: 28758844
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the chitosan-functionalized graphene oxide as a carrier for loading thioguanine, an antitumor drug and effect of urea on adsorption process: Combination of DFT computational and molecular dynamics simulation studies.
Hasanzade Z; Raissi H
J Biomol Struct Dyn; 2019 Jul; 37(10):2487-2497. PubMed ID: 30052134
[TBL] [Abstract][Full Text] [Related]
15. Hydration patterns of graphene-based nanomaterials (GBNMs) play a major role in the stability of a helical protein: a molecular dynamics simulation study.
Baweja L; Balamurugan K; Subramanian V; Dhawan A
Langmuir; 2013 Nov; 29(46):14230-8. PubMed ID: 24144078
[TBL] [Abstract][Full Text] [Related]
16. Structural insight of DNA topoisomerases I from camptothecin-producing plants revealed by molecular dynamics simulations.
Sirikantaramas S; Meeprasert A; Rungrotmongkol T; Fuji H; Hoshino T; Sudo H; Yamazaki M; Saito K
Phytochemistry; 2015 May; 113():50-6. PubMed ID: 25733498
[TBL] [Abstract][Full Text] [Related]
17. Theoretical elucidation of the amino acid interaction with graphene and functionalized graphene nanosheets: insights from DFT calculation and MD simulation.
Kamel M; Raissi H; Hashemzadeh H; Mohammadifard K
Amino Acids; 2020 Oct; 52(10):1465-1478. PubMed ID: 33098474
[TBL] [Abstract][Full Text] [Related]
18. Electronic-property dependent interactions between tetracycline and graphene nanomaterials in aqueous solution.
He L; Liu FF; Zhao M; Qi Z; Sun X; Afzal MZ; Sun X; Li Y; Hao J; Wang S
J Environ Sci (China); 2018 Apr; 66():286-294. PubMed ID: 29628096
[TBL] [Abstract][Full Text] [Related]
19. Structure and properties of camptothecin derivatives, their protonated forms, and model interaction with the topoisomerase I-DNA complex.
Ivanova B; Spiteller M
Biopolymers; 2012 Feb; 97(2):134-44. PubMed ID: 21898362
[TBL] [Abstract][Full Text] [Related]
20. Modulation in kinetics of lactone ring hydrolysis of camptothecins upon interaction with topoisomerase I cleavage sites on DNA.
Chourpa I; Riou JF; Millot JM; Pommier Y; Manfait M
Biochemistry; 1998 May; 37(20):7284-91. PubMed ID: 9585542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
